TUBERCULOSIS PREVALENCE AND RISK FACTORS DURING HAJJ SEASON 1440
Main Article Content
Keywords
Abstract
Tuberculosis (TB) is a persistent global public health challenge, affecting millions annually. The Hajj pilgrimage brings together over two million Muslims from diverse regions, creating conditions conducive to the spread of infectious diseases. This retrospective study investigates TB prevalence during the 1440 Hajj season using data from healthcare facilities in Makkah. The findings reveal a prevalence rate of 2.8% and highlight significant risk factors, including overcrowding, delayed medical attention, and comorbidities such as diabetes. These findings contribute to improved preventive strategies for TB during mass gatherings, providing a global health benefit by informing policy recommendations to reduce risks in similar high-density settings worldwide. Recommendations include improved pre-travel screening, targeted public health interventions, and enhanced international collaboration to reduce TB risks during mass gatherings.
Downloads
References
1. Al-Orainey IO (2013). Tuberculosis infection during Hajj pilgrimage: The risk to pilgrims and their communities. Saudi Medical Journal, 34(7), 676–680. 2. WHO (2016). Global Tuberculosis Report. Geneva: WHO. 3. Yezli S, Zumla A, et al. (2017). Undiagnosed active pulmonary tuberculosis among pilgrims during the 2015 Hajj. American Journal of Tropical Medicine and Hygiene, 97(5), 1304–1309. 4. Zumla A, Memish ZA, Al-Tawfiq JA (2014). Mass gatherings and infectious diseases: prevention, detection, and control. Lancet Infectious Diseases, 14(1), 56-66. 5. Memish ZA, Zumla A, Alhakeem RF, et al. (2014). Hajj: infectious disease surveillance and control. Lancet, 383(9934), 2073-2082. 6. Gautret P, Steffen R. (2016). Communicable diseases as health risks at mass gatherings other than Hajj: what is the evidence? International Journal of Infectious Diseases, 47, 46-52. 7. Wilder-Smith A, Foo W, Earnest A, et al. (2005). Seroepidemiology of dengue in the adult population of Singapore. Tropical Medicine & International Health, 10(3), 301-308. 8. Al-Tawfiq JA, Memish ZA. (2019). Infection control measures for the prevention of respiratory tract infections during mass gatherings: Lessons from the Hajj. Clinical Microbiology and Infection, 25(2), 198-202. 9. Memish ZA, Alrabeeah AA, Zumla A. (2013). Hajj: preparations for mass gathering to minimize the risk of infectious disease outbreaks. Lancet Infectious Diseases, 13(10), 828-836. 10. Alqahtani AS, Wiley KE, Tashani M, et al. (2016). Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross-sectional studies before and after Hajj. International Journal of Infectious Diseases, 47, 53-59. 11. Yezli S, Assiri AM, Alhakeem RF, et al. (2018). MERS-CoV in the Hajj and Umrah pilgrimages: an update. Travel Medicine and Infectious Disease, 25, 26-31. 12. Memish ZA, Ahmed QA, Schlagenhauf P, et al. (2010). Hajj: infectious disease surveillance and control. Lancet, 375(9712), 1209-1219. 13. Tashani M, Alfelali M, Barasheed O, et al. (2015). Pneumococcal vaccine uptake among Hajj pilgrims: A retrospective cohort study. Vaccine, 33(22), 2563-2569. 14. Ahmed QA, Arabi YM, Memish ZA. (2006). Health risks at the Hajj. Lancet, 367(9515), 1008-1015. 15. Barasheed O, Almasri N, Alqudeimat Y, et al. (2016). Uptake of influenza vaccine among Hajj pilgrims: Barriers and policy implications. Travel Medicine and Infectious Disease, 14(1), 48-53. 16. Khan K, Sears J, Hu VW, et al. (2013). Potential for the international spread of Middle East respiratory syndrome in association with mass gatherings in Saudi Arabia. PLOS Current Outbreaks. 17. Hoang VT, Gautret P. (2018). Infectious diseases and mass gatherings. Current Infectious Disease Reports, 20(11), 44. 18. Alfelali M, Barasheed O, Tashani M, et al. (2015). Influenza vaccine effectiveness among Hajj pilgrims: A test-negative case-control analysis. Journal of Travel Medicine, 22(6), 377-385. 19. Wilder-Smith A, Freedman DO. (2009). Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. Journal of Travel Medicine, 27(2). 20. Sridhar S, Brouqui P, Parola P, et al. (2012). Travellers and emerging infections: Sentinel networks and syndromic surveillance. International Journal of Infectious Diseases, 16(6), e407-e413. 21. Alqahtani AS, Rashid H, Basyouni MH, et al. (2017). Exploring factors associated with compliance with preventive measures for infectious diseases among Hajj pilgrims: a cross-sectional study. Infection Control & Hospital Epidemiology, 38(6), 727-732. 22. Barasheed O, Alfelali M, Bokhary H, et al. (2016). Uptake and effectiveness of facemask against respiratory infections at mass gatherings: A systematic review. International Journal of Infectious Diseases, 47, 105-111. 23. Memish ZA, Assiri AM, Turkestani A, et al. (2012). Mass gatherings and global health: case studies from the Hajj to Mecca. Annals of Global Health, 78(4), 145-154. 24. Ahmed QA, Memish ZA. (2020). The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19. Travel Medicine and Infectious Disease, 34, 101631. 25. Gautret P, Benkouiten S, Salaheddine I, et al. (2016). Preventive measures for respiratory infections at Hajj: policies and practice. Journal of Travel Medicine, 23(4).
Article Sidebar
Article Details
Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.